Presentation

At MYRA, we believe a healthier population starts with reading the body’s earliest signals, not waiting until a diagnosis arrives too late. We exist to find disease before it finds you. Not for the fortunate few. For entire populations.

This gap is not theoretical. Across the conditions that quietly shape a population’s health, from metabolic disease to workforce fatigue to hormonal transitions, the pattern repeats. The body signals risk early, but the system sees it late. This is not a funding problem. It’s a visibility problem. Health systems are blind between check-ups, and that blindness drives avoidable illness, avoidable cost, and avoidable loss of human potential.

Our mission is to save the lives lost to diseases that are entirely curable through early detection, and to improve lives through health insights that no test or app can offer today.

When we get this right, we don’t just preserve and improve life. We strengthen a country’s productivity, resilience, and return economic value that dwarfs the cost of prevention.

As a consumer facing health-tech scale-up, MYRA is building the biosensor platform that makes this possible: continuous biomarker monitoring, engineered to sit under the skin as an invisible wearable capturing the signals that matter for early detection.

This creates a dataset that has never existed before. One that trains AI models to deliver health insight at both the individual and population level, transforming a single annual check-up into a continuous, always-on picture of a nation’s health.